But the agency said later it was re-evaluating the decision that the shortage is over amid litigation, putting compounding of ...

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

The FDA, however, warns that reports in a database aren’t yet verified and don’t mean the drugs have actually caused the harms reported.

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

The FDA has issued a warning regarding compounded drugs distributed by Fullerton Wellness, LLC, in Ontario, California.

When starting prescription weight loss medications, getting approval from a doctor and insurance is one of the hardest parts.

The FDA recently said it would reconsider taking tirzepatide off the shortages list. Companies like Hims & Hers and Noom have ...

Results from a retrospective cohort study show lower all-cause mortality and fewer hospitalizations and intestinal ...

With a positive readout for metabolic dysfunction-associated steatohepatitis (MASH) now in the bag, Novo Nordisk is gearing ...